Wednesday, July 8, 2026

biotech · Dental Caries · Cystic Fibrosis · ARMP

Armata Pharmaceuticals

Armata Pharmaceuticals is a biotech organization headquartered in Freehold, USA. It trades on NYSE under ticker ARMP. Primary therapeutic focus areas include Dental Caries, Cystic Fibrosis, Non-cystic Fibrosis Bronchiect

Freehold, USA HQ
2018 Founded
18 Employees
Public company Type
ARMP · NYSE Ticker
Company details
Status
Public
HQ
Freehold, USA
Founded
2018
Employees
18
Programs
9
Drugs
0
Patents
5
Clinical program

C16G2 Varnish

Phase 2 · small molecule · Dental Caries

C16G2 Varnish for Dental Caries is a Phase 2 program (small_molecule) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).

← All Armata Pharmaceuticals projects Phase 2 small molecule completed

Internal code C3J16-V204-00

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Armata Pharmaceuticals
Phase
Phase 2
Modality
small_molecule
Indication
Dental Caries
Status
completed
Trials
1

Clinical trials